October 18, 2017

Genentech, Inc. et al v. Amgen, Inc.

Track this case

Case overview

Case Number:

1:17-cv-01471

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory M. Sleet

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 27, 2017

    Amgen 'Completely Ignoring' Biosimilar Law, Genentech Says

    Amgen Inc. has been “completely ignoring” its information-disclosure obligations under the federal biosimilars law in order to shield its biosimilar of blockbuster cancer drug Avastin, Genentech Inc. claims in a newly unsealed complaint.


Parties

To view the parties, register now.